Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.

ABSTRACT:

Objectives

To assess the performance of the commercially available Magmaris sirolimus-eluting bioresorbable scaffold (BRS) with invasive imaging at different time points.

Background

Coronary BRS with a magnesium backbone have been recently studied as an alternative to polymeric scaffolds, providing enhanced vessel support and a faster resorption rate. We aimed to assess the performance of the commercially available Magmaris sirolimus-eluting BRS at different time points.

Methods

A prospective, single-center, nonrandomized study was performed at the Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands. Six patients with stable de novo coronary artery lesions underwent single-vessel revascularization with the Magmaris sirolimus-eluting BRS. Invasive follow-u

SUBMITTER: Tovar Forero MN 

PROVIDER: S-EPMC7027819 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature